brecht ingelbeen
@ingelbeen.bsky.social
infectious disease epidemiologist into antimicrobial resistance and population based studies. also a bit of urban cycling #EpiSky #IDSky
For me, it's sobering to realize that another year passed while most primary care practices and hospitals around the world still lack a structural approach or resources to tackling #AMR.
Luckily the relentless energy of those AMR advocates offers an annual boost of morale
Luckily the relentless energy of those AMR advocates offers an annual boost of morale
November 22, 2025 at 10:49 AM
For me, it's sobering to realize that another year passed while most primary care practices and hospitals around the world still lack a structural approach or resources to tackling #AMR.
Luckily the relentless energy of those AMR advocates offers an annual boost of morale
Luckily the relentless energy of those AMR advocates offers an annual boost of morale
Every year during #WorldAntimicrobialAwarenessWeek I'm surprised by the diversity of media, approaches, and key messages used to reach and mobilize the public or healthcare workers, and to promote better antibiotic use—driven each time by the tireless and unparalleled energy of so many AMR advocates
November 22, 2025 at 10:46 AM
Every year during #WorldAntimicrobialAwarenessWeek I'm surprised by the diversity of media, approaches, and key messages used to reach and mobilize the public or healthcare workers, and to promote better antibiotic use—driven each time by the tireless and unparalleled energy of so many AMR advocates
😱😱 it's not just the abstract
October 21, 2025 at 7:40 AM
😱😱 it's not just the abstract
a global health journal gives you a limit of 200 words for the abstract of an article you've been working on for years so you decide to use these words to provide historical context 😬 #AMR
October 21, 2025 at 7:29 AM
a global health journal gives you a limit of 200 words for the abstract of an article you've been working on for years so you decide to use these words to provide historical context 😬 #AMR
Great work at GLASS that @esthervk.bsky.social presented at #ESCMIDglobal, providing regional trends in AMR prevalence in bloodstream infections #AMR #IDSky
April 30, 2025 at 6:45 AM
Great work at GLASS that @esthervk.bsky.social presented at #ESCMIDglobal, providing regional trends in AMR prevalence in bloodstream infections #AMR #IDSky
GLASS report with 2022 AMU data is out #IDSky #AMR
iris.who.int/bitstream/ha...
It has per capita antibiotic use expressed in DDD per 1000 inhabitants per day, confirming DID is lower in most low-income than in most high-income countries
Would be great to link population-wide AMU to AMR prevalence
iris.who.int/bitstream/ha...
It has per capita antibiotic use expressed in DDD per 1000 inhabitants per day, confirming DID is lower in most low-income than in most high-income countries
Would be great to link population-wide AMU to AMR prevalence
April 29, 2025 at 12:30 PM
GLASS report with 2022 AMU data is out #IDSky #AMR
iris.who.int/bitstream/ha...
It has per capita antibiotic use expressed in DDD per 1000 inhabitants per day, confirming DID is lower in most low-income than in most high-income countries
Would be great to link population-wide AMU to AMR prevalence
iris.who.int/bitstream/ha...
It has per capita antibiotic use expressed in DDD per 1000 inhabitants per day, confirming DID is lower in most low-income than in most high-income countries
Would be great to link population-wide AMU to AMR prevalence
Vienna was marvelous and going from Copenhagen to ESCMID by day- and nightrain was a fantastic experience
April 15, 2025 at 10:06 AM
Vienna was marvelous and going from Copenhagen to ESCMID by day- and nightrain was a fantastic experience
7. Two sessions on AMR and vaccines demonstrated again the lack of (recent) studies measuring effectiveness of (new+existing) vaccines on reducing antimicrobial use and AMR. Willian Hausdorff suggested developing combination vaccines by clinical presentation could better convince policy makers
April 15, 2025 at 9:49 AM
7. Two sessions on AMR and vaccines demonstrated again the lack of (recent) studies measuring effectiveness of (new+existing) vaccines on reducing antimicrobial use and AMR. Willian Hausdorff suggested developing combination vaccines by clinical presentation could better convince policy makers
6. Erika Vlieghe gave a talk on developing a sepsis national action plan in Belgium and had to start with a disclaimer on the complexity of healthcare decisionmaking, having to deal with 7 health ministers. Preventive and curative care are dealt with by different state levels.
April 15, 2025 at 9:48 AM
6. Erika Vlieghe gave a talk on developing a sepsis national action plan in Belgium and had to start with a disclaimer on the complexity of healthcare decisionmaking, having to deal with 7 health ministers. Preventive and curative care are dealt with by different state levels.
5. Sonephet Vantava demonstrated how in hospitals in Lao PDR, healthcare worker attitudes and PPS antibiotic use data from will be combined to inform #AMS addressing frequent antibiotic use before and after delivery. Knowledge influences attitudes differently by profession @icarsglobal.bsky.social
April 15, 2025 at 9:48 AM
5. Sonephet Vantava demonstrated how in hospitals in Lao PDR, healthcare worker attitudes and PPS antibiotic use data from will be combined to inform #AMS addressing frequent antibiotic use before and after delivery. Knowledge influences attitudes differently by profession @icarsglobal.bsky.social
Vilada Chansamouth then demonstrated how they used pathogen distribution and AMR prevalence data to develop guidelines in Lao PDR
April 15, 2025 at 9:46 AM
Vilada Chansamouth then demonstrated how they used pathogen distribution and AMR prevalence data to develop guidelines in Lao PDR
4. A session on AMR surveillance gave excellent examples of analyzing and using clin micro AMR surveillance data, largely all examples from SE Asia. Many LMIC still struggle analyzing the data they have. Would be great if @WHO copy-pastes more from these examples
April 15, 2025 at 9:45 AM
4. A session on AMR surveillance gave excellent examples of analyzing and using clin micro AMR surveillance data, largely all examples from SE Asia. Many LMIC still struggle analyzing the data they have. Would be great if @WHO copy-pastes more from these examples
3. A session on biomarkers reviewed evidence on use of CRP to treat outpatient respi tract infections or fevers in low-resource settings. Large differences in effectiveness largely due to differences in antibiotic use prevalence. A cheap single malaria +semiquantitative CRP lateral flow test awaited
April 15, 2025 at 9:43 AM
3. A session on biomarkers reviewed evidence on use of CRP to treat outpatient respi tract infections or fevers in low-resource settings. Large differences in effectiveness largely due to differences in antibiotic use prevalence. A cheap single malaria +semiquantitative CRP lateral flow test awaited
2. On relevant metrics to evaluate #AMS interventions: Days of Antibiotic Spectrum Coverage/DASC not only measures days of treatment but also at how wide the spectrum is of the antibiotic administered. Narrowing treatment is measured, and thus effectiveness in limiting selective pressure
April 15, 2025 at 9:40 AM
2. On relevant metrics to evaluate #AMS interventions: Days of Antibiotic Spectrum Coverage/DASC not only measures days of treatment but also at how wide the spectrum is of the antibiotic administered. Narrowing treatment is measured, and thus effectiveness in limiting selective pressure
Nee (wat het artikel ook concludeert)
Is dit nu misinformation of disinformation @de-standaard.bsky.social?
Is dit nu misinformation of disinformation @de-standaard.bsky.social?
March 2, 2025 at 10:24 AM
Nee (wat het artikel ook concludeert)
Is dit nu misinformation of disinformation @de-standaard.bsky.social?
Is dit nu misinformation of disinformation @de-standaard.bsky.social?
Solution: Monitoring of different risks—such as exposure proxies (e.g., repeated environmental sampling), pathogen characteristics (e.g., resistance genes), and human behavior (e.g., mobility data)—can provide real-time insights into outbreak potential, supplementing case-based surveillance. 2/5
February 18, 2025 at 8:08 AM
Solution: Monitoring of different risks—such as exposure proxies (e.g., repeated environmental sampling), pathogen characteristics (e.g., resistance genes), and human behavior (e.g., mobility data)—can provide real-time insights into outbreak potential, supplementing case-based surveillance. 2/5
NEW PAPER: When and how to embed risk data in infectious disease surveillance?
Problem: Traditional infectious disease surveillance consisting of facility-based reporting of cases, often delays outbreak response due to disease progression, healthcare seeking, diagnostic and reporting lags. 1/5
Problem: Traditional infectious disease surveillance consisting of facility-based reporting of cases, often delays outbreak response due to disease progression, healthcare seeking, diagnostic and reporting lags. 1/5
February 18, 2025 at 8:08 AM
NEW PAPER: When and how to embed risk data in infectious disease surveillance?
Problem: Traditional infectious disease surveillance consisting of facility-based reporting of cases, often delays outbreak response due to disease progression, healthcare seeking, diagnostic and reporting lags. 1/5
Problem: Traditional infectious disease surveillance consisting of facility-based reporting of cases, often delays outbreak response due to disease progression, healthcare seeking, diagnostic and reporting lags. 1/5
Researchers at the National Centre of Maternity and Childhood Care in Bishkek, Kyrgyzstan, evaluated the use of CRP to guide antibiotic prescribing in children with acute respiratory tract infections in primary care in a RCT #IDSky
doi.org/10.1016/j.la...
doi.org/10.1016/j.la...
January 20, 2025 at 8:20 AM
Researchers at the National Centre of Maternity and Childhood Care in Bishkek, Kyrgyzstan, evaluated the use of CRP to guide antibiotic prescribing in children with acute respiratory tract infections in primary care in a RCT #IDSky
doi.org/10.1016/j.la...
doi.org/10.1016/j.la...
A study evaluating the effect of introducing typhoid conjugate vaccine in Zimbabwe did also not find an important change in antibiotic use.
Even with typhoid largely controlled, prescribers' uncertainty on other potential bacterial causes remained
www.thelancet.com/journals/lan...
Even with typhoid largely controlled, prescribers' uncertainty on other potential bacterial causes remained
www.thelancet.com/journals/lan...
November 26, 2024 at 8:11 AM
A study evaluating the effect of introducing typhoid conjugate vaccine in Zimbabwe did also not find an important change in antibiotic use.
Even with typhoid largely controlled, prescribers' uncertainty on other potential bacterial causes remained
www.thelancet.com/journals/lan...
Even with typhoid largely controlled, prescribers' uncertainty on other potential bacterial causes remained
www.thelancet.com/journals/lan...
Effect of vaccines on antibiotic use: using attributable fractions of diarrhoea episodes in birth cohorts in Bangladesh, India, Nepal, Pakistan and Tanzania, a study estimated the hypothetical effect of 6 single + 3 combined vaccines on antibiotic use #EpiSky #IDSky www.thelancet.com/journals/lan...
November 26, 2024 at 7:41 AM
Effect of vaccines on antibiotic use: using attributable fractions of diarrhoea episodes in birth cohorts in Bangladesh, India, Nepal, Pakistan and Tanzania, a study estimated the hypothetical effect of 6 single + 3 combined vaccines on antibiotic use #EpiSky #IDSky www.thelancet.com/journals/lan...
"while 5% of health spending is on prevention, 50% of the reduction in mortality rate is attributable to prevention" Chris Dye (UOxford) #ESCAIDE
November 20, 2024 at 8:54 AM
"while 5% of health spending is on prevention, 50% of the reduction in mortality rate is attributable to prevention" Chris Dye (UOxford) #ESCAIDE